模板:抗抑鬱藥

跳轉到: 導航, 搜索

抗抑鬱藥 (N06A)

特效重攝取抑制劑 (RIs), 強化劑 (REs), 和釋放劑 (RAs)

選擇性5-羥色胺再吸收抑制劑 (SSRIs)	阿拉丙酯西酞普蘭依地普侖非莫西汀氟苯氧丙胺^# 氟伏沙明茚達品伊福西汀利托西汀魯巴唑酮 Omiloxetine 帕奴拉明帕羅西汀吡喃達明塞羅西汀舍曲林^# 齊美定^‡

羥色胺去甲腎上腺素再攝取抑制劑 (SNRIs)	氯伏胺去甲文拉法辛度洛西汀左旋體米那普侖依氯那明米那普侖西布曲明文拉法辛

羥色胺去甲腎上腺素多巴胺再攝取抑制劑 (SNDRIs)	Amitifadine 比西發定 Brasofensine BTS-74,398 Cocaine 雙氮奮興 DOV-21,947 DOV-102,677 DOV-216,303 EXP-561 非唑拉明 JNJ-7925476 NS-2359 PRC200-SS Pridefine SEP-225,289 SEP-227,162 Tesofensine

Norepinephrine reuptake inhibitors (NRIs)	氨甲達林 Atomoxetine/Tomoxetine 苯奈達林氫苯嘧吲哚達來達林 Edivoxetine 惡潑西汀氯他拉明嗎吲哚尼索西汀瑞波西汀他洛普侖他舒普侖坦達明維洛沙秦

多巴胺再攝取抑制劑 (DRIs)	美地沙明伐諾司林

去甲腎上腺素多巴胺再攝取抑制劑 (NDRIs)	阿米庚酸安非他酮^# 西洛巴明 Manifaxine 哌甲酯諾米芬辛 Radafaxine 他美曲林

去甲腎上腺素多巴胺釋放劑 (NDRAs)	苯丙胺苯呋拉林二甲磺酸賴右苯丙胺甲基苯丙胺苯乙胺吡貝拉林反苯環丙胺

Serotonin-norepinephrine-dopamine releasing agents (SNDRAs)	4-Methyl-αMT αET/Etryptamine αMT/Metryptamine

Selective serotonin reuptake enhancers (SSREs)	Tianeptine

Others	Indeloxazine Teniloxazine Tramadol Viqualine

受體拮抗劑和/或再攝取抑制劑

羥色胺拮抗劑和再攝取抑制劑 (SARIs)	依託哌酮奈法唑酮曲唑酮

去甲基腎上腺素及特殊血清素再攝取抑制劑 (NaSSAs)	Aptazapine Esmirtazapine Mianserin Mirtazapine Setiptiline/Teciptiline

Norepinephrine-dopamine disinhibitors (NDDIs)	Agomelatine

Serotonin modulators and stimulators (SMSs)	Vortioxetine

Others	Tedatioxetine Vilazodone

雜環類抗抑鬱 (雙環, 三環, 和四環)

Bicyclics	Tiazesim Tofenacin

Tricyclics	Amezepine Amineptine Amitriptyline^# Amitriptylinoxide Azepindole Butriptyline Cianopramine Clomipramine Cotriptyline Cyanodothiepin Demexiptiline Depramine/Balipramine Desipramine Dibenzepin Dimetacrine Dosulepin/Dothiepin Doxepin Enprazepine Fluotracen Hepzidine Homopipramol Imipramine Imipraminoxide Intriptyline Iprindole Ketipramine Litracen Lofepramine Losindole Mariptiline Melitracen Metapramine Mezepine Naranol Nitroxazepine Nortriptyline Noxiptiline Octriptyline Opipramol Pipofezine Propizepine Protriptyline Quinupramine Tampramine Tianeptine Tienopramine Trimipramine

Tetracyclics	Amoxapine Aptazapine Azipramine Ciclazindol Ciclopramine Esmirtazapine Maprotiline Mazindol Mianserin Mirtazapine Oxaprotiline Setiptiline/Teciptiline

單胺氧化酶抑制劑 (MAOIs)

Nonselective	Irreversible: Benmoxin Carbenzide Cimemoxin Domoxin Echinopsidine Iproclozide Iproniazid Isocarboxazid Mebanazine Metfendrazine Nialamide Octamoxin Phenelzine Pheniprazine Phenoxypropazine Pivalylbenzhydrazine Safrazine Tranylcypromine Reversible: Caroxazone Paraxazone Quercetin

MAO_A-Selective	Irreversible: Clorgiline Reversible: Amiflamine Bazinaprine Befloxatone Befol Berberine Brofaromine Cimoxatone Esuprone Harmala Alkaloids (Harmine Harmaline Tetrahydroharmine Harman Norharman, etc) Methylene Blue Metralindole Minaprine Moclobemide Pirlindole Sercloremine Tetrindole Toloxatone Tyrima

MAO_B-Selective	Irreversible: Ladostigil Mofegiline Pargyline Rasagiline Selegiline Reversible: Lazabemide Milacemide

氮雜螺酮和其他5-HT_1A 受體激動劑

阿奈螺酮阿立哌唑貝非拉醇丁螺環酮依他匹隆氟辛克生氟立班絲氨吉哌隆伊沙匹隆奧沙氟生坦度螺酮維拉佐酮扎螺酮

^#世衛基本藥物WHO-EM ^‡從市場撤回臨床試驗：^†第三階段 ^§未到第三階段

Template:Psychology navs

Template:Collapsible sections option

2個分類: 抗抑鬱藥物 | 採用ATC碼的藥物模板

個人工具

登入／建立新賬號

功能菜單

工具箱